Skip to main content

Table 3 Mean visit values and mean differences between visits (baseline and follow-up) as measured by the same operators in the healthy subjects and ESRD groups

From: Reproducibility of carotid-femoral pulse wave velocity in end-stage renal disease patients: methodological considerations

Parameter

Group

Mean visit values

Mean difference

p value

± SD

(95 % CI)

Carotid-femoral PWV

cf-PWV (m/s)

HS

6.4 ± 1.3

−0.4 (−1.0 to 0.1)

0.130

ESRD

8.7 ± 2.8

+0.1 (−0.75 to 1.0)

0.780

Subtracted cf-distance (mm)

HS

465 ± 31

+1.0 (−7.3 to 9.2)

0.820

ESRD

470 ± 35

−6.9 (−18.8 to 5.0)

0.240

cf mean time (ms)

HS

77 ± 13

+0.6 (−3.7 to 4.9)

0.780

ESRD

60 ± 21

+1.7 (−4.3 to 7.6)

0.571

SBP (mmHg)

HS

117 ± 12

−2.3 (−5.3 to 0.7)

0.130

ESRD

137 ± 19

−6.9 (−14.2 to 0.5)

0.070

DBP (mmHg)

HS

70 ± 9

−1.3 (−2.9 to 0.3)

0.100

 

ESRD

67 ± 10

−2.6 (−5.3 to 0.2)

0.070

Radial artery PWA

AIx@HR75 (%)

HS

15 ± 14

+2.6 (−0.1 to 5.2)

0.053

ESRD

23 ± 11

−7.7 (−3.8 to 2.2)

0.610

Central pulse pressure (mm Hg)

HS

35 ± 5

−0.4 (−2.2 to 1.5)

0.680

ESRD

57 ± 20

−2.0 (−7.0 to 3.1)

0.430

  1. AIx@HR75 augmentation index corrected for heart rate at 75 beats per minute, cf carotid femoral, CI confidence interval, DBP diastolic blood pressure, ESRD end-stage renal disease, HS healthy subjects, PWA pulse wave analysis, PWV pulse wave velocity (m/s), SBP systolic blood pressure